Ipca Laboratories Hits 52-Week High; Campus Activewear Forecasts Steady Growth

Ipca Laboratories' stock reached a 52-week high, driven by strong quarterly revenue, better-than-expected earnings, and growth in its domestic formulation segment. The company projects 10-11% year-on-year growth for FY26. Meanwhile, Campus Activewear, supported by product innovation and premiumisation, is expected to grow steadily with a projected CAGR of 12% in revenue and 18% in EBITDA through FY28, despite slight EBITDA estimate cuts due to increased marketing expenses.